LU84946A1 - Procede de preparation de glycoproteines anti-tumeurs - Google Patents

Procede de preparation de glycoproteines anti-tumeurs Download PDF

Info

Publication number
LU84946A1
LU84946A1 LU84946A LU84946A LU84946A1 LU 84946 A1 LU84946 A1 LU 84946A1 LU 84946 A LU84946 A LU 84946A LU 84946 A LU84946 A LU 84946A LU 84946 A1 LU84946 A1 LU 84946A1
Authority
LU
Luxembourg
Prior art keywords
glycoprotein
tumor
group
molecular weight
cells
Prior art date
Application number
LU84946A
Other languages
English (en)
French (fr)
Inventor
Haruo Ohnishi
Yasuo Suzuki
Ei Mochida
Kazuo Yamaguchi
Nobuo Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of LU84946A1 publication Critical patent/LU84946A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LU84946A 1982-08-04 1983-08-04 Procede de preparation de glycoproteines anti-tumeurs LU84946A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13585282 1982-08-04
JP57135852A JPS5925332A (ja) 1982-08-04 1982-08-04 抗腫瘍性糖蛋白質の製法

Publications (1)

Publication Number Publication Date
LU84946A1 true LU84946A1 (fr) 1983-12-28

Family

ID=15161271

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84946A LU84946A1 (fr) 1982-08-04 1983-08-04 Procede de preparation de glycoproteines anti-tumeurs

Country Status (21)

Country Link
JP (1) JPS5925332A (no)
KR (1) KR840006127A (no)
AU (1) AU1759283A (no)
BE (1) BE897470A (no)
BR (1) BR8304143A (no)
DD (1) DD213440A5 (no)
DE (1) DE3328239A1 (no)
DK (1) DK356483A (no)
FI (1) FI832776A (no)
FR (1) FR2531435A1 (no)
GB (1) GB2125048A (no)
GR (1) GR78638B (no)
IT (1) IT8348806A0 (no)
LU (1) LU84946A1 (no)
NL (1) NL8302765A (no)
NO (1) NO832811L (no)
PL (1) PL243306A1 (no)
PT (1) PT77154B (no)
SE (1) SE8304276L (no)
YU (1) YU161983A (no)
ZA (1) ZA835680B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073293B1 (no) * 1969-12-31 1973-01-12 Pasteur Institut
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons

Also Published As

Publication number Publication date
DD213440A5 (de) 1984-09-12
KR840006127A (ko) 1984-11-22
NL8302765A (nl) 1984-03-01
NO832811L (no) 1984-02-06
IT8348806A0 (it) 1983-08-03
BR8304143A (pt) 1984-03-13
DE3328239A1 (de) 1984-02-16
YU161983A (en) 1986-02-28
PL243306A1 (en) 1984-08-27
DK356483A (da) 1984-02-05
BE897470A (fr) 1984-02-06
FR2531435A1 (fr) 1984-02-10
JPS5925332A (ja) 1984-02-09
FI832776A0 (fi) 1983-08-02
GR78638B (no) 1984-09-27
SE8304276D0 (sv) 1983-08-04
DK356483D0 (da) 1983-08-04
GB2125048A (en) 1984-02-29
SE8304276L (sv) 1984-02-05
FI832776A (fi) 1984-02-05
ZA835680B (en) 1984-08-29
PT77154A (en) 1983-09-01
GB8320547D0 (en) 1983-09-01
PT77154B (en) 1986-01-28
AU1759283A (en) 1984-02-09

Similar Documents

Publication Publication Date Title
JP2002508736A (ja) ペプチジルプロドラッグ及びそれの製法と使用方法
FR2516794A1 (fr) Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
EP0037388B1 (fr) Formes pharmaceutiques, leur préparation et les compositions qui les contiennent
EP3353191A1 (fr) Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique
CN1037350C (zh) 制备多肽衍生物的方法
FR2556220A1 (fr) Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leur production et leurs utilisations
JPWO2006040980A1 (ja) レシチン化スーパーオキシドディスムターゼ組成物およびその製造方法
FR2601678A1 (fr) Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
LU84946A1 (fr) Procede de preparation de glycoproteines anti-tumeurs
EP0397571A1 (fr) Utilisation du caséinoglycopeptide k pour la fabrication d'une composition, notamment d'un médicament, pour la prévention et le traitement des thromboses
EP1536808B1 (fr) L'heterocarpine, une proteine d origine vegetale aux proprietes anticancereuses
FR2615737A1 (fr) Preparation et utilisation d'interferon-gamma
EP1409531B1 (fr) L'heterocarpine, une proteine fixant le ghrh humain
FR2516924A1 (fr) Acides phosphinylalcanoyl- amines a action therapeutique
CN112110924B (zh) 6-S,9-N-(二乙酰-Lys-OBzl-巯基)嘌呤,其合成,活性和应用
FR2572936A1 (fr) Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations
CH633716A5 (en) Method for separating and purifying products having interferon activity, purified preparations having interferon activity and use of the preparations
CA1250810A (fr) Hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
CA3091948A1 (en) New treatments of multiple myeloma
US6015878A (en) Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
EP0357495A2 (fr) Dérivés de la 3'azido-3' déoxythymidine (AZT) actifs contre le virus du sida
CA2115972A1 (fr) Derives cyclopeptidiques de l'angiopeptine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2003267995A (ja) 新規なヘプタペプチドおよびアンジオテンシン変換酵素阻害剤
RU2182491C2 (ru) Пептиды с контринсулярным действием
DE102010036261A1 (de) Peptidgebundene α-Hydroxy-4(1H)-pyridinon-Derivate, Verfahren zu deren Herstellung und deren Verwendung